Gushengtang TCM, a leading Traditional Chinese Medicine group, is set to expand its footprint in Singapore by opening 30 clinics by 2026. The company plans to integrate its proprietary ‘Master TCM AI’ system, which was recently launched at GovWare 2025, to enhance patient care through data-backed, evidence-informed practices.
The expansion is part of a strategic partnership with August Global Partners, a Singapore-based fund management company. This collaboration aims to generate S$1b in revenue over the next seven years by focusing on clinic expansion, AI-powered clinical systems, and international product certification.
The ‘Master TCM AI’ system is designed to support physicians across eight specialities, including oncology and dermatology, by providing evidence-informed recommendations and tracking treatment outcomes. “Our collaboration with 1doc and August Global Partners marks an important milestone in integrating Traditional Chinese Medicine into Singapore’s healthcare ecosystem,” said Vicky Liem, Vice President of Gushengtang TCM Group.
Additionally, Gushengtang has partnered with 1doc, a subsidiary of IAPPS Health Group, to integrate TCM into Western family clinics. This partnership allows patients to access both TCM and Western medical care under one roof, aligning with Singapore’s TCM Integrative Sandbox Initiative.
Gushengtang’s expansion aligns with Singapore’s healthcare vision of integrating traditional and modern medicine, offering a coordinated, evidence-based approach to patient care. The company views Singapore as a gateway for international growth and a testbed for digital health integration.
